Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis;Maladie de Kawasaki résistante aux immunoglobulines et compliquée de syndrome d'activation macrophagique

Archives de Pediatrie

Volumn 19, Issue 7, 2012, Pages 741-744

  Servel, A C ^a   Vincenti, M ^a   Darras, J P ^c   Lalande, M ^a   Rodiere M ^a   Filleron, A ^a,b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b UNIVERSITÉ MONTPELLIER 2   (France)

^c Centre Hospitalier de Narbonne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; INFLIXIMAB;

ADOLESCENT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

ADOLESCENT; DRUG RESISTANCE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 84862657065     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/j.arcped.2012.04.016     Document Type: Article

References (20)

1. Newburger J.W., Takahashi M., Gerber M.A., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004, 114:1708-1733.
2. Rowley A.H., Shulman S.T. Recent advances in the understanding and management of kawasaki disease. Curr Infect Dis Rep 2010, 12:96-102.
3. Burns J.C., Glode M.P. Kawasaki syndrome. Lancet 2004, 364:533-544.
4. Bresson V., Bonello B., Rousset-Rouviere C., et al. Maladie de Kawasaki chez le grand enfant et l'adulte jeune: expérience marseillaise sur 10ans. Arch Pediatr 2011, 18:731-736.
5. Egritas O., Nacar N., Hanioglu S., et al. Early but prolonged gallbladder hydrops in a 7-month-old girl with Kawasaki syndrome: report of a case. Surg Today 2007, 37:162-164.
6. Zulian F., Falcini F., Zancan L., et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr 2003, 142:731-735.
7. Titze U., Janka G., Schneider E.M., et al. Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis. Pediatr Blood Cancer 2009, 53:493-495.
8. Al-Eid W., Al-Jefri A., Bahabri S., et al. Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol 2000, 17:323-329.
9. Palazzi D.L., McClain K.L., Kaplan S.L. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J 2003, 22:663-666.
10. Latino G.A., Manlhiot C., Yeung R.S., et al. Macrophage activation syndrome in the acute phase of Kawasaki disease. J Pediatr Hematol Oncol 2010, 32:527-531.
11. Thabet F., Bellara I., Tabarki B., et al. Colite ischémique et syndrome d'hémophagocytose compliquant une maladie de Kawasaki. Arch Pediatr 2004, 11:226-228.
12. Simonini G., Pagnini I., Innocenti L., et al. Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. Pediatr Blood Cancer 2010, 55:592.
13. Karras A., Hermine O. Syndrome d'activation macrophagique. Rev Med Interne 2002, 23:768-778.
14. Kumar S., Vaidyanathan B., Gayathri S., et al. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Rheumatol Int 2010, Dec 5. [Epub ahead of print]. 10.1007/s00296-010-1650-8.
15. Son M.B., Gauvreau K., Burns J.C., et al. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr 2011, 158:644-9e1.
16. Lang B.A., Yeung R.S., Oen K.G., et al. Corticosteroid treatment of refractory Kawasaki disease. J Rheumatol 2006, 33:803-809.
17. Hashino K., Ishii M., Iemura M., et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001, 43:211-217.
18. Maury C.P., Salo E., Pelkonen P. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med 1989, 113:651-654.
19. Burns J.C., Mason W.H., Hauger S.B., et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005, 146:662-667.
20. Burns J.C., Best B.M., Mejias A., et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 2008, 153:833-838.